By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Action Pharma 

Brendstrupgaardsvej 102

Arhus    DK-8200  Denmark
Phone: 45-2020-3687 Fax: n/a


SEARCH JOBS








Company News
Abbott Laboratories (ABT) Buys AP214 Hormone From Action Pharma for $110 Million 5/3/2012 10:49:10 AM
Action Pharma's Phase 2b Clinical Trial with AP214 to Prevent Kidney Injury Associated with Major Cardiac Surgery Demonstrates Positive Top-Line Results 9/26/2011 8:00:19 AM
Action Pharma Completes Last Patient Last Visit in Phase IIb Trial with AP214 8/8/2011 10:46:38 AM
Action Pharma Completes Dosing in Phase IIb Clinical Trial with AP214 to Prevent Acute Kidney Injury Associated with Cardiac Surgery 5/9/2011 9:50:52 AM
Action Pharma Initiates Phase IIb Clinical Trial in the USA And Denmark With AP214 to Prevent Kidney Injury Associated With Major Cardiac Surgery 11/8/2010 1:26:42 PM
Action Pharma Obtains Positive Results in A Phase II Clinical Trial With AP214 to Prevent Acute Kidney Injury Associated With Cardiac Surgery 9/13/2010 3:51:54 PM
Action Pharma Raises Eur 5 Million 6/9/2010 7:25:56 AM
Action Pharma Obtains Encouraging Preliminary Results In A Phase II Clinical Trial With AP214 6/7/2010 12:30:10 PM
Action Pharma Completes EUR 5 Million (6.1Million USD) Financing Round To Advance Its Lead Project AP214 6/3/2010 11:40:38 AM
Action Pharma Focuses Its Strategy And Appoints Ingelise Saunders As New CEO 3/24/2010 11:31:16 AM
12
//-->